PERNIX THERAPEUTICS

pernix-therapeutics-logo

Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products primarily for the pediatric market. The Companyโ€™s pediatric products, designed to improve the health and well-being of children, are focused in the specific areas of allergy, upper respiratory, including nasal, chest congestion and cough, antibiotics and dermatology, including head lice, and contact dermatitis. The Company prom... otes its products through a sales and marketing organization with approximately 55 sales representatives, primarily in highly populated states, targeting pediatric and high-prescribing physicians that are in the top decile of physicians that prescribe its products. The Companyโ€™s current operating plan focuses on maximizing sales of its existing product portfolio. In addition, Pernix plans to accelerate growth by launching new products, line extensions, and new formulations and by acquiring and licensing approved products.

#People #Financial #Website #More

PERNIX THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1997-01-01

Address:
Houston, Texas, United States

Country:
United States

Website Url:
http://www.curraxpharma.com

Total Employee:
251+

Status:
Active

Contact:
800-793-2145

Total Funding:
99 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 GoDaddy DNS Google Google Cloud



Current Advisors List

not_available_image

Michael C. Pearce Board Member @ Pernix Therapeutics
Board_member

steven-a-elms_image

Steven A. Elms Board Director @ Pernix Therapeutics
Board_member

Current Employees Featured

not_available_image

Steve A. Elms
Steve A. Elms Director @ Pernix Therapeutics
Director

not_available_image

Michael Venters
Michael Venters Vice President of Corporate Development @ Pernix Therapeutics
Vice President of Corporate Development

doug-drysdale_image

Doug Drysdale
Doug Drysdale CEO, Chairman & Board of Directors @ Pernix Therapeutics
CEO, Chairman & Board of Directors
2014-02-05

george-hampton_image

George Hampton
George Hampton CEO @ Pernix Therapeutics
CEO

Stock Details


Company's stock symbol is NASDAQ:PTX

Acquisitions List

Date Company Article Price
2013-03-06 Somaxon Pharmaceuticals Somaxon Pharmaceuticals acquired by Pernix Therapeutics 25 M USD
2012-11-14 Cypress Pharmaceutical Cypress Pharmaceutical acquired by Pernix Therapeutics 91 M USD

Investors List

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Post-IPO Debt - Pernix Therapeutics

Official Site Inspections

http://www.curraxpharma.com

  • Host name: 104.26.10.236
  • IP address: 104.26.10.236
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Pernix Therapeutics" on Search Engine